**EXHIBIT      31.1**

**CERTIFICATION      PURSUANT TO 17 CFR 240.13(a)-14(a)**

**(SECTION      302 CERTIFICATION)**

|   | a)     |   | Designed                such disclosure controls and procedures or caused such disclosure                controls                and procedures to be designed under our supervision, to ensure that                material information relating to China Healthcare Acquisition Corp.,                including its consolidated subsidiaries, is made known to us by others                within those entities, particularly during the period in which this                report                is being prepared; |
|--------|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|   | b)     |   | Evaluated                the effectiveness of China Healthcare Acquisition Corp.’s disclosure                controls and procedures and presented in this report our conclusions                about                the effectiveness of the disclosure controls and procedures, as of                the end                of the period covered by this report based on such evaluation;                and                                                                                                    |
|   |   |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|   | c)     |   | Disclosed                in this report any changes in China Healthcare Acquisition Corp.’s                internal control over financial reporting that occurred during China                Healthcare Acquisition Corp.’s most recent fiscal year that has materially                affected, or is reasonably likely to materially affect, China Healthcare                Acquisition Corp.’s internal control over financial                reporting.                                          |

|                                    | a)                                                      |   | All                significant deficiencies and material weaknesses in the design or                operation of internal control over financial reporting which are                reasonably likely to adversely affect China Healthcare Acquisition                Corp.’s                ability to record, process, summarize and report financial information;                and |
|-----------------------------------------|---------------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                    |                                                    |   |                                                                                                                                                                                                                                                                                                                                                                                          |
|                                    | b)                                                      |   | Any                fraud, whether or not material, that involves management or other                employees who have a significant role in China Healthcare Acquisition                Corp.’s internal controls over financial reporting.                                                                                                                                            |
|                                    |                                                    |   |                                                                                                                                                                                                                                                                                                                                                                                          |   |
|                                    |                                                    |   |
| Date:                May 14, 2008  | /s/                Alwin Tan                       |   |
|                                    | Alwin                Tan, Chief Executive Officer  |   |
|                                    |                                                    |   |
|                                    |